Navigation Links
2009 Prix Galien USA Now Accepting Nominations for Top Prize in Biopharmaceutical Research and Development
Date:3/11/2009

NEW YORK, March 11 /PRNewswire-USNewswire/ -- The committee responsible for awarding the most prestigious prize in biopharmaceutical research and development -- Prix Galien USA -- announced it is accepting 2009 nominations. For the first time, the committee will include a new recognition category for best medical device. It also has expanded the eligibility window to the past decade.

Prix Galien USA is now awarded in three categories that offer broad implications for future biomedical research: best pharmaceutical agent, best biotechnology product and best medical device. All pharmaceutical and biological drugs or devices approved by the U.S. Food and Drug Administration for first or new indications between 1998 and 2008 are eligible for nomination in 2009. This new eligibility period will permit the judges to determine both the immediate and the long-term impact these pharmaceuticals, biotechnology products and devices have had on human health and disease.

"The Prix Galien USA committee is delighted to be able to honor the impact medical devices have on human health," said Gerald Weissmann, M.D., Prix Galien USA committee chair, research professor of medicine at New York University and editor-in-chief of The FASEB Journal. "When we consider how new pharmaceuticals, biotechnology products and devices have changed our lives, it is clear that we have entered a new era of medical discovery."

The committee, which includes six Nobel Laureates, will honor the ingenuity of the biopharmaceutical industry at its annual gala event on September 30 at the American Museum of Natural History in New York. Online nominations for Prix Galien USA 2009 are being accepted through June 1st http://submission.prix-galien-usa.com.

Selzentry(TM) (Pfizer Inc.), Isentress(R) (Merck & Co., Inc.), Soliris(R) (Alexion Pharmaceuticals, Inc.), INFUSE(R) (Wyeth) and Revlimid(R) (The Celgene Corporation) were recognized by the Prix Galien USA committee in 2008 for applications that address pervasive illness and diseases.

The Prix Galien Award recognizes technical, scientific and clinical research skills necessary to develop innovative medicines and devices, and is considered the industry's highest accolade -- equivalent to the Nobel Prize. The Prix Galien USA award committee comprises 11 individuals including Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals. For details about the Prix Galien USA award and committee visit www.prix-galien-usa.com.


'/>"/>
SOURCE Prix Galien Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Prix Galien USA Welcomes Eighth Nobel Laureate to its Prestigious Award Committee
2. Prix Galien USA Recognizes Biotech, Pharmaceutical Industries for Innovative Medical Treatments
3. Inspiring Authors Tell Inspirational Stories: Special Writers Find Accepting Home at Lulu.com
4. PA Governors Occupational Safety and Health Conference Still Accepting Registrations
5. UIC College of Nursing in Peoria Now Accepting Applications for New Doctorate of Nursing Practice
6. Joint Commission, National Quality Forum Now Accepting Applicants for the 2008 John M. Eisenberg Patient Safety and Quality Awards
7. Gates Foundation Now Accepting Proposals for Grand Challenges Explorations
8. SEIU RN Dian Palmer Calls on AFL-CIO Head John Sweeney to Review Video From Dearborn Protest, Retract Statement Accepting CNA Distortions
9. American Sentinel University Accepting Enrollment in Online RN to BS in Nursing
10. American Pain Society Accepting Applications for Clinical Centers of Excellence in Pain Management Awards
11. PRN Funding Now Accepting Credit Cards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “Knowledge is ... be guided by faith. “Knowledge is God’s Lighthouse” is the creation of published author, ... cookbooks, novels, and poetry collections. , “I have been writing since high school ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... Management System: an On-demand E-learning system for Clinical and Regulatory education for ... is based on Aerolib`s successful education methodology of Disease Specific Documentation Improvement. ...
(Date:1/19/2017)... ... January 19, 2017 , ... This month, the CEO ... the name of their drug rehab center in Delray Beach, Florida has been changed ... not only stars such as Philip Seymour Hoffman and Chris Farley are dying from ...
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... Cosmetic ... of plastic surgery procedures in order to make it easier for their readers to ... of the body they impact as well as the techniques used on those particular ...
(Date:1/19/2017)... IL (PRWEB) , ... January 19, 2017 , ... ... N.A., announced it recently provided a new $11,250,000 senior credit facility to Sunrise, ... new MB credit facility were used to facilitate a recapitalization of MedPro led ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 ... ... Forecast 2016-2026: Opportunities for Leading Companies – our new ... new report discusses issues and events affecting the Alzheimer,s ... qualitative analyses to answer these key questions: - How ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... 2017 Accuray Incorporated (Nasdaq: ARAY ... continue to set the bar for excellence in customer ... user satisfaction rating among radiation treatment delivery systems in ... Market Intelligence Briefing™. The most recent ratings trend also ... industry peers for 11 of the past 12 quarters. ...
Breaking Medicine Technology: